Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemia
- 1 April 1979
- journal article
- research article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 25 (1), 45-58
- https://doi.org/10.1016/0009-2797(79)90068-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Hydroxylation de l'ellipticine chez le rat: structure des deux principaux métabolites. Synthèse de l'hydroxy-7 ellipticineTetrahedron Letters, 1978
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersEuropean Journal of Cancer (1965), 1978
- Some antitumor derivatives of ellipticine deprived of mutagenic propertiesChemico-Biological Interactions, 1977
- The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated ratsBiochemical Pharmacology, 1977
- Aromatic hydroxylation of ellipticine in rats: Lack of an NIH shiftJournal of Mass Spectrometry, 1976
- Toxicological and pharmacological studies on 9-hydroxy-ellipticine in miceToxicology and Applied Pharmacology, 1975
- Biochemical effects of ellipticine on leukemia L1210 cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1974
- A new DNA intercalating drug: Methoxy‐9‐ellipticineFEBS Letters, 1971
- A fluorescent complex between ethidium bromide and nucleic acidsJournal of Molecular Biology, 1967
- Synthesis of the tumour-inhibitory alkaloids, ellipticine, 9-methoxyellipticine, and related pyrido[4,3-b]carbazolesAustralian Journal of Chemistry, 1967